Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cyslabdan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Bioinformatic mining of the Streptomyces thermocarboxydus K155 genome predicted the presence of four synthases for the production… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2016
Review
2016
  • Hiroshi Tomoda
  • Chemical & pharmaceutical bulletin
  • 2016
  • Corpus ID: 207176506
Methicillin-resistant Staphylococuss aureus (MRSA) is a major nosocomial pathogen that has developed resistance to many… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2016
2016
Cyslabdan was isolated from the culture broth of Streptomyces sp. K04-0144 as a new potentiator of imipenem activity against… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2016
2016
Methicillin-resistant Staphylococuss aureus (MRSA) is a major nosocomial pathogen that has developed resistance to many… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Genome mining of cyslabdan-producing Streptomycescyslabdanicus K04-0144 revealed that a set of four genes, cldA, cldB, cldC, and… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2015
2015
Actinomycete strains OM-6519T and K04–0144T produce the bioactive compounds lactacystin and cyslabdan, respectively. Here, the… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2012
2012
The nonantibiotic small molecule cyslabdan, a labdan-type diterpene produced by Streptomyces sp. K04-0144, markedly potentiated… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Review
2012
Review
2012
  • Hiroshi Tomoda
  • Yakugaku zasshi : Journal of the Pharmaceutical…
  • 2012
  • Corpus ID: 39589030
Methicillin-resistant Staphylococcus aureus (MRSA) is known as a major nosocomial pathogen that has also developed resistance to… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2008
2008
AbstractCyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, was isolated from… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2008
2008
AbstractCyslabdan produced by Streptomyces sp. K04-0144 was found to potentiate imipenem activity against methicillin-resistant… Expand
  • figure 1
  • table 1
  • table 3
  • table 2
Is this relevant?